研究者業績

稲熊 岳

Inaguma Gaku

基本情報

所属
藤田医科大学 医学部 総合消化器外科学 講師

J-GLOBAL ID
201601012729488226
researchmap会員ID
7000015615

論文

 6
  • Gaku Inaguma, Junichiro Hiro, Koki Otsuka, Koji Masumori, Yosuke Kobayashi, Yongchol Chong, Yusuke Omura, Yutaka Hattori, Kazuki Tsujimura, Ichiro Uyama, Koichi Suda
    Asian Journal of Endoscopic Surgery 2024年10月  
  • Ayaka Ito, Yusuke Omura, Junichiro Hiro, Kazuki Tsujimura, Yutaka Hattori, Megumu Kamishima, Yosuke Kobayashi, Gaku Inaguma, Yongchol Chong, Koji Masumori, Koki Otsuka, Ichiro Uyama, Koichi Suda
    Asian Journal of Endoscopic Surgery 2024年4月  
  • Gaku Inaguma
    Surgical endoscopy 2022年9月9日  
    The current study aimed to investigate the relationship between muscle mass proportion and the incidence of total complications in male gastric cancer (GC) patients after minimally invasive distal gastrectomy (MIDG). Between March 2017 and March 2020, 152 male GC patients with clinical stage III or lower GC who underwent MIDG were enrolled in this study. The muscle mass ratio (MMR) was calculated by dividing the total muscle weight obtained from bioelectrical impedance analysis by the whole-body weight. Thereafter, the association between MMR and surgical outcomes was determined. Based on the optimal MMR cutoff value of 0.712 obtained using the receiver operating characteristic (ROC) curve, patients were divided into two groups (69 and 83 patients in the MMR-L and MMR-H groups). The MMR-L group had a significantly higher total complication rate compared to the MMR-H group (MMR-L, 24.6% vs. MMR-H, 7.2%; P = 0.005). Multivariate analysis also identified MMR-L as a significant independent risk factor for total complications and intra-abdominal infectious complications after MIDG. The MMR calculated using bioelectrical impedance analysis can be a useful predictor for postoperative complications after MIDG in male GC patients.
  • Gaku Inaguma, Yosuke Tajima, Junichiro Hiro, Tsunekazu Hanai, Hidetoshi Katsuno, Koji Masumori, Yoshikazu Koide, Hiroshi Matsuoka, Tomoyoshi Endo, Tadahiro Kamiya, Yongchol Chong, Harunobu Sato, Kotaro Maeda, Ichiro Uyama, Koichi Suda
    Asian Journal of Endoscopic Surgery 15(2) 401-404 2022年4月  
  • Tsunoda, J., Nishi, T., Ito, T., Inaguma, G., Matsuzaki, T., Seki, H., Yasui, N., Sakata, M., Shimada, A., Matsumoto, H.
    World Journal of Clinical Cases 10(20) 2022年  
  • Gaku Inaguma
    Surgical case reports 2020年11月11日  
    <h4>Background</h4>Dermatomyositis is associated with malignant tumors including breast cancer, and inflammatory breast cancer is considered to have a poorer prognosis than most breast cancers.<h4>Case presentation</h4>A 74-year-old Asian woman, developed erythema on her face, back, and the back of her hands, 3 weeks before attending our department. At the same time, she had noticed a right breast mass and redness of the skin of the breast. The clinical findings and vacuum aspiration biopsy diagnosed inflammatory breast cancer and neoadjuvant chemotherapy was performed. The mass and enlarged axillary lymph nodes had shrunk, therefore a total mastectomy was performed. The sentinel lymph node biopsy was negative. She was discharged 7 days after surgery without any complications. She has received a postoperative aromatase inhibitor and is alive without recurrence. The dermatomyositis also began to improve with the start of her chemotherapy and has not recurred since the surgery.<h4>Conclusions</h4>Neoadjuvant chemotherapy was performed for inflammatory breast cancer with dermatomyositis, and tumor shrinkage was confirmed. A total mastectomy without axillary lymph node dissection was performed. Dermatomyositis and breast cancer have not recurred. Dermatomyositis may have been a paraneoplastic syndrome due to breast cancer.